"Cancer Cells Fuse with Immune Cells in Human Patients
The hybrid cells promote tumor heterogeneity and possible metastasis, a new study in mice and humans shows" @CICS_DR_MARQUEZ@patologia_oma
https://t.co/qsD31Bbogy. Let’s link the ribbons to STOP cancer, many years & a lot of wasted funding but few clinical facts. Why? Ideas are welcome. Is the clinical oncology & cancer research obsolete? Is time to rethink about these topics in order to have zero or less suffering
@bettyparedon Yo espero tener a Sonora como país. Mexico personalmente aún, cuando sonora es aún parte de el, siento que con todo el respeto que Mexico merece,sonora merece ser un país digno y recuerden que de aquí salió la única actriz MF que dijo “no te equivoques en Sonora nace la belleza”
Avail Early Bird Offer on Registration and Accommodation
It is with immense pleasure we are organizing “34th Euro Global Summit on #CancerTherapy & #RadiationOncology” July 25-27,2019 at #London,UK
Visit: https://t.co/VJBU5zFCq4 Inform us @ [email protected]
The main characteristic of the Binational Immunooncology Alliance from Seattle & Sonora is to develop new treatment guidelines w/ less clinical & economical toxicity. So,the key to cure cancer is performing clinically relevant research. Here Clinical cases treated successfully.
https://t.co/HCMTuY3Jff. Oncotip: microbiota & Cancer. For now is in Spanish.Take a home message:the “normal” microbiota contains microorganisms that promote tumor formation & we can modulate it w/ easy stuff such a green tea consumption. Last picture: celebrating PDAC remission
Sarcoma is a rare tumor & few clinically relevant research is around the corner.This is especially because most of the researchers focus on either clinically IRRELEVANT TARGETS or in only few of them.We really need to block simultaneously multiple pathways in order to STOP tumors
Pancreatic cancer has a dark prognosis. Unfortunately this is especially because most of the researchers focus on either clinically IRRELEVANT TARGETS. Plus they only block few of them.Interesting, many researchers ignore a big topic in PC: the tumor stroma & microenvironment.
In case you like to help this wonderful 20 years old with refractory sarcoma. Now the tumor is responding very well to the multi peptide immunotherapy + immunogenic chemotherapy + cytokine immunomodulation + Repurposing Drugs + tumor microenvironment immunomodulation
In case you like to help this wonderful 20 years old with refractory sarcoma. Now the tumor is responding very well to the multi peptide immunotherapy + immunogenic chemotherapy + cytokine immunomodulation + Repurposing Drugs + tumor microenvironment immunomodulation @uicc
https://t.co/DAGfednDfW oncotips for the general population, video recorded during our clinical oncology meeting 2018 in Dublin, Ireland. Here the little one Travis & Zarahemla in the pathway to remission from sarcoma, our first collaborator in PDAC Theresa Brentnall as & Thelma
https://t.co/OlZMmgLXXN. Oncotip: microbiota & Cancer. For now is in Spanish.Take a home message:the “normal” microbiota contains microorganisms that promote tumor formation & we can modulate it w/ easy stuff such a green tea consumption. Last picture: celebrating PDAC remission
Un gusto volver a estar presente en las pláticas organizadas por CICS y escuchar la ponencia “Importancia del laboratorio clínico en oncología” 💉🔬👩🏻🔬👨🏻⚕️impartido por Diana Ayon @CICS_DLAF @CICS_DR_MARQUEZ